Cost-effectiveness and availability of alternative treatment options play a crucial role in the listing of new medicines in South Korea. However, high-cost medicines with no alternative treatment options, particularly those for treating cancer and rare diseases, were not reimbursed under the traditional route.
How the government of South Korea addresses this issue? Learn more from this policy brief.
Health Intervention and Technology Assessment Program Foundation
Head Office : 88/22 Moo 4, 6th Building, 6th Floor, Department of Health, Ministry of Public Health, Tiwanon Road, Taladkwan Subdistrict, Muang Nonthaburi District, Nonthaburi 11000, Thailand
Tel. : +662-590-4549, +662-590-4374-5
Fax : +662-590-4369
E-mail : [email protected]
Website : www.hitap.net
